Literature DB >> 937359

Renal transport of urate during diuretic-induced hypouricemia.

O G Reese, T H Steele.   

Abstract

The effect of two weeks administration of a uricosuric diuretic (SKF-62698) on renal urate handling has been examined in 11 normal men. Plasma urate concentrations had declined by more than 60 per cent after two weeks. Urate excretion per unit of glomerular filtration rate and urate clearance (Curate) per unit of glomerular filtration rate were increased after the administration of SKF-62698. The importance of intact tubular secretion of urate in producing these changes was assessed by administering pyrazinamide, an agent that curtails urate secretion, to each participant. The decrements in urate excretion and clearance produced by pyrazinamide both increased significantly, whereas the residual urate excretion rates and clearances not suppressible by pyrazinamide were only minimally altered by SKF-62698 treatment. These results suggest that the excretion of secreted urate was enhanced by prolonged administration of SKF-62698, probably secondary to the inhibition of postsecretory urate reabsorption. In addition, because the nonsuppressible urate excretion did not decline despite a 63 per cent reduction in the plasma urate, it is likely that the reabsorption of filtered urate also was impaired by SKF-62698.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937359     DOI: 10.1016/0002-9343(76)90569-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Authors:  Garry G Graham; Diluk R W Kannangara; Sophie L Stocker; Ian Portek; Kevin D Pile; Praveen L Indraratna; Indira Datta; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

2.  Acute reversible renal impairment produced by a uricosuric diuretic.

Authors:  F A Hubbell; M A Weber; B B Megaffin; D D Brewer
Journal:  West J Med       Date:  1980-11

3.  Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function.

Authors:  J B Myers; A Gillies; S Waga; T O Morgan
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

4.  The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.

Authors:  M W Johnson; W E Mitch
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

5.  Uric acid, diuretics and the kidney.

Authors: 
Journal:  West J Med       Date:  1978-11

6.  Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.

Authors:  W Löffler; R Landthaler; J X de Vries; I Walter-Sack; A Ittensohn; A Voss; N Zöllner
Journal:  Clin Investig       Date:  1994-12

7.  Multicentre comparative trial of tienilic acid and hydrochlorothiazide in hypertensive patients.

Authors:  C Ponticelli; A Lechi; T di Perri; B Redaelli; F Locatelli; E Rivolta; G Covi; G L Messa; G Pincella; L Pedrini; M Recchia; P Gouère
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

8.  Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

Review 9.  Urate Handling in the Human Body.

Authors:  David Hyndman; Sha Liu; Jeffrey N Miner
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.